Dry Eye Disease | NYU Langone Health
NYU Langone ophthalmologists treat people with dry eye disease with innovative procedures that relieve discomfort and preserve eye health.
Duration of Time After Knee Intra-articular Injection to Pain Relief
We will identify patients who undergo injections of corticosteroids, hyaluronic acid, or platelet rich plasma for relief of osteoarthritis of the knees. We will then assess patient reported outcomes and number of days until pain relief. We will do this via a telephone or email survey and chart review.
During Your Child’s Hospital Stay | NYU Langone Health
We offer tips on what to expect during your child’s stay at Hassenfeld Children’s Hospital at NYU Langone.
Dysautonomia Center | NYU Langone Health
NYU Langone’s Dysautonomia Center is dedicated to improving the lives of people with autonomic disorders, offering a range of treatment options.
Dysautonomia Center Doctors | NYU Langone Health
Find a doctor at the Dysautonomia Center at NYU Langone.
Ear, Nose, Throat & Mouth Conditions | NYU Langone Health
NYU Langone ear, nose, throat, and mouth (ENT) specialists provide children and adults with comprehensive services for a range of conditions.
Early Cardiovascular Disease Detection Program | NYU Langone Health
NYU Langone’s Center for the Prevention of Cardiovascular Disease offers an Early Cardiovascular Disease Detection Program.
Early Childhood Services at Family Health Centers at NYU Langone | NYU Langone Health
Early childhood services are provided through Family Health Centers at NYU Langone’s Community-Based Programs.
Early Cochlear Implant Use
This study focuses on newly activated cochlear implant users. Cochlear implants are auditory neuroprostheses that restore hearing to folks with significant degrees of hearing loss. These users are expected to attain significant levels of speech perception
EARLY DETECTION OF ALPHA-SYNUCLEIN DISEASE Single-center cross-sectional and longitudinal non-interventional observational study of biomarkers in prodromal synucleinopathy
Single-center, cross-sectional and longitudinal exploratory observational study of approximately 80 patients with diagnoses of pure autonomic failure (PAF), Parkinson´s Disease, Multiple System Atrophy, Lewy Body Dementia and prodromal patients with or without REM-sleep behavior disorder (RBD), early motor signs of parkinsonism and autonomic abnormalities without definitive diagnosis, who are considered prodromal forms a-synuclein disease. We will use novel a-synuclein seed amplification assays (SAA) to detect pathologic a-synuclein conformers in skin biopsies of patients with PD, MSA LBD or PAF, to validate these assays for early detection of a-synuclein. Also, the study will characterize early disease in patients with suggestive early neurologic symptoms prior to significant neurodegeneration. Finally, the assay will inform as to a-synuclein strain identity that can differentiate risk of PD/DLB vs. MSA. These assays will be complemented by clinical, cognitive, olfactory, assessments, and Brain imaging with dopamine transporter (DAT)-SPECT and brain MRI if available in the chart. Eligible patients will be followed with annual clinical assessments, with single additional collection of biomarkers and imaging if they demonstrate conversion to major degenerative synucleinopathy.